发明名称 |
SOLID VALSARTAN PHARMACEUTICAL COMPOSITION |
摘要 |
PROBLEM TO BE SOLVED: To provide a solid oral administration form comprising a pharmaceutically effective amount of valsartan or a pharmaceutically permissible salt or solvate thereof. SOLUTION: The oral solid pharmaceutical composition contains valsartan or a pharmaceutically permissible salt or hydrate thereof as an activator and a disintegrating agent, wherein the weight ratio of the activator to a disintegrator is 2.9:1 to 1:1, and 20 mg unit dosage of the activator is contained. The composition is at least 1.2 times more bioavailable than conventional valsartan capsules. COPYRIGHT: (C)2007,JPO&INPIT
|
申请公布号 |
JP2007091758(A) |
申请公布日期 |
2007.04.12 |
申请号 |
JP20070003546 |
申请日期 |
2007.01.11 |
申请人 |
NOVARTIS AG |
发明人 |
GANTER SABINA MARIA;WAGNER ROBERT FRANK |
分类号 |
A61K9/16;A61K31/41;A61K9/20;A61K9/48;A61K47/04;A61K47/12;A61K47/32;A61K47/36;A61K47/38;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P13/12;A61P25/28;A61P43/00 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|